Preview

Russian Sklifosovsky Journal "Emergency Medical Care"

Advanced search

WHAT CHANGES IN PERFUSION AND MYOCARDIAL FUNCTION AFTER LATE REVASCULARIZATION OF ACUTE MYOCARDIAL INFARCTION?

https://doi.org/10.23934/2223-9022-2017-6-2-118-123

Abstract

Aim. To determine the influence of the time gap between acute myocardial infarction with ST-segment elevation and intracoronary intervention performed later than 2.5 hours on myocardium, we studied indicators of perfusion over time with an aid of SPECT, including intraventricular asynchrony (2–4 days and 6–8 months after stent installation).

Materials and method. We observed 22 patients with multivessel coronary lesion. The Russian program with the analysis of perfusion, function and the phase images was used in SPECT synchronized with ECG.

Results. Showed that the time gap prior to coronary intervention in the acute phase of myocardial infarction may be directly connected with the increase in impaired perfusion during the end-systole and the severity of pathological intraventricular asynchrony without ECG signs. All patients had significantly decreased wall mobility and intraventricular asynchrony together with increased R-R interval in the late period (after 6–8 months) independently from the coronary intervention time. In patients of group 1 (coronary intervention within 6 hours), focal transmural lesions of myocardium significantly decreased.

Conclusion. Late revascularization help decrease intraventricular asynchrony reducing the risk of heart failure in future. 

About the Authors

E. N. Ostroumov
N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health Department
Russian Federation

Dr. Med. Sci., Professor, Researcher of the Department of Radioisotope Diagnostics,

Moscow



E. V. Migunova
N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health Department
Russian Federation
Moscow


E. D. Kotina
N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health Department
Russian Federation
Moscow


O. G. Sinyakova
N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health Department
Russian Federation
Moscow


G. A. Gazaryan
N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health Department
Russian Federation
Moscow


V. A. Ryabinin
N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health Department
Russian Federation
Moscow


N. E. Kudryashova
N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health Department
Russian Federation
Moscow


References

1. Kolh P., Windecker S., Alfonso F., et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2014; 46(4): 517–592. PMID: 25173601. DOI: 10.1093/ejcts/ezu366.

2. Miedema M.D., Newell M.C., Duval S., et al. Causes of delay and associated mortality in patients transferred with ST-segment-elevation myocardial infarction. Circulation. 2011; 124(15): 1636–1644. PMID: 21931079. DOI: 10.1161/CIRCULATIONAHA.111.033118

3. Kim C.B., Braunwald E. Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. Circulation. 1993; 88 (5 Pt 1): 2426–2436. PMID: 8222135.

4. Ostroumov E.N., Kotina E.D., Slobodyanik V.V. ECG-synchronized myocardial perfusion tomoscintigraphy and cardiac resynchronization therapy. Rossiyskiy kardiologicheskiy zhurnal. 2011; 3: 58–65. (In Russian).

5. Ostroumov E.N., Kotina E.D., Slobodyanik V.V., et al. Super-response to cardiac resynchronization therapy and myocardial scintigraphy in patients with heart failure. Vrach. 2014; 3: 50–53. (In Russian).

6. Marcassa C., Bax J.J., Bengel F., et al. Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement. Eur Heart J. 2008; 29(4): 557–563. PMID: 18202253. DOI: 10.1093/eurheartj/ehm607.

7. Udelson J.E., Pearte C.A., Kimmelstiel C.D., et al. The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention vs. optimal medical therapy alone. Am Heart J. 2011; 161(3): 611–621. PMID: 21392619. DOI: 10.1016/j.ahj.2010.11.020.

8. Dzavík V., Buller C.E., Lamas G.A., et al. TOSCA-2 Investigators. Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function. The Total Occlusion Study of Canada (TOSCA)-2 trial. Circulation. 2006; 114(23): 2449–2457. PMID: 17105848. DOI: 10.1161/CIRCULATIONAHA.106.669432.

9. Revishvili A. Sh., Neminushchiy N. M. Cardiac resynchronizing therapy in treatment of chronic heart failure. Vestnik aritmologii. 2007; 48: 47–57. (In Russian).

10. Lin Y.J., Chien K.L., Chen H.K., et al. Left Ventricular Dyssynchrony Predicts Left Main Coronary Artery Disease in Patients with Non-STSegment Elevation Myocardial Infarction. Acta Cardiol Sin. 2015; 31(3): 226–231. PMID: 27122874.

11. Alam I., Haque T., Badiuzzaman M., et al. Left Ventricular Dyssynchrony in Acute ST Elevated Myocardial Infarction in Patients with Normal QRS duration. Bangladesh Heart Journal. 2015; 30(1): 13–21. DOI: http://dx.doi.org/10.3329/bhj.v30i1.28129.

12. Shin S.H. , Hung C.L., Uno H., et al. for the Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Mechanical Dyssynchrony After Myocardial Infarction in Patients With Left Ventricular Dysfunction, Heart Failure, or Both. Circulation. 2011; 121(9): 1096–1103. PMID: 20176989. DOI: 10.1161/CIRCULATIONAHA.109.863795.

13. Manrique A. , Lemarchand P., Delasalle B., et al. Predictors of ventricular remodelling in patients with reperfused acute myocardial infarction and left ventricular dysfunction candidates for bone marrow cell therapy: insights from the BONAMI trial. Eur J Nucl Med Mol Imaging. 2016; 43(4): 740–748. PMID: 26666236. DOI: 10.1007/s00259-015-3279-z.

14. Murrow J., Esteves F., Galt J., et al. Characterization of mechanical dyssynchrony measured by gated single photon emission computed tomography phase analysis after acute ST-elevation myocardial infarction. J Nucl Cardiol. 2011; 18(5): 912–919. PMID: 21717276. DOI: 10.1007/s12350-011-9414-8.


Review

For citations:


Ostroumov E.N., Migunova E.V., Kotina E.D., Sinyakova O.G., Gazaryan G.A., Ryabinin V.A., Kudryashova N.E. WHAT CHANGES IN PERFUSION AND MYOCARDIAL FUNCTION AFTER LATE REVASCULARIZATION OF ACUTE MYOCARDIAL INFARCTION? Russian Sklifosovsky Journal "Emergency Medical Care". 2017;6(2):118-123. (In Russ.) https://doi.org/10.23934/2223-9022-2017-6-2-118-123

Views: 960


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2223-9022 (Print)
ISSN 2541-8017 (Online)